I 
117TH CONGRESS 
1ST SESSION H. R. 2636 
To direct the Secretary of Health and Human Services to submit to Congress 
a report on the security and resilience of the United States medical 
supply chains, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 16, 2021 
Mr. TRONE (for himself and Mr. JOYCE of Pennsylvania) introduced the 
following bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To direct the Secretary of Health and Human Services to 
submit to Congress a report on the security and resil-
ience of the United States medical supply chains, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Strengthening our 
Health Security Through Resilient Medical Supply Chains 
Annual Review Act of 2021’’. 
VerDate Sep 11 2014 
02:13 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2636.IH
H2636
pbinns on DSKJLVW7X2PROD with BILLS
SEC. 2. REPORT ON SECURITY AND RESILIENCE OF THE 
UNITED STATES MEDICAL SUPPLY CHAINS. 
(a) IN GENERAL.—Not later than one year after the 
date of the enactment of this Act, and annually thereafter, 
the Secretary of Health and Human Services shall submit 
to the Committee on Energy and Commerce of the House 
of Representatives, and the Committee on Health, Edu-
cation, Labor and Pensions of the Senate a report on the 
security and resilience of the United States medical supply 
chains. Such a report shall contain a classified annex. 
(b) PUBLIC AVAILABILITY.—The Secretary shall— 
(1) make publicly available (including by publi-
cation on the website of the Department of Health 
and Human Services) the unclassified portion of the 
report under subsection (a); and 
(2) make every reasonable effort to protect 
trade secret information and commercially confiden-
tial information. 
(c) CONTENTS.—The report submitted under sub-
section (a) shall— 
(1) review the United States supply chains for 
medical devices, supplies, and drugs and the vulner-
ability of such supply chains to a global disruption, 
such as an instance of bioterrorism, a natural dis-
aster, or a public health emergency; 
VerDate Sep 11 2014 
02:13 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2636.IH
H2636
pbinns on DSKJLVW7X2PROD with BILLS
(2) assess the dependence of the United States 
on any medical devices, equipment, supplies, coun-
termeasures, vaccines, and drugs produced or 
sourced outside the United States; 
(3) identify the actions the Federal government 
has taken during the year covered by the report— 
(A) to promote the security and resilience 
of the United States medical supply chain; 
(B) to improve medical supply chain re-
dundancy; 
(C) to encourage the domestic production 
of medical devices, equipment, supplies, coun-
termeasures, vaccines, and drugs; and 
(D) to develop contingency plans for poten-
tial global disruptions; and 
(4) provide recommendations to agencies of the 
Federal Government, States, local, tribal, and terri-
torial governments, and the private sector on ways 
to strengthen the security and resilience of the 
United States medical supply chain. 
(d) CONSULTATION.—In preparing the report under 
subsection (a), the Secretary of Health and Human Serv-
ices— 
(1) shall consult with the heads of other rel-
evant Federal agencies; and 
VerDate Sep 11 2014 
02:13 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2636.IH
H2636
pbinns on DSKJLVW7X2PROD with BILLS
(2) may consult with public health experts, 
health security experts, supply chain experts, and 
other individuals with relevant experience. 
Æ 
VerDate Sep 11 2014 
02:13 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H2636.IH
H2636
pbinns on DSKJLVW7X2PROD with BILLS